Related Experiment Videos
New in vitro line from a human (B) non-Hodgkin lymphoma
L Kopper1, A Bankfalvi, R Mihalik
11st Institute of Pathology, Semmelweis Medical University, Budapest, Hungary.
Insights
A new human B-cell lymphoma cell line (HT 58) was developed from a xenograft. This cell line maintains key lymphoma characteristics and produces molecules that stimulate B-cell growth.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Non-Hodgkin lymphoma (NHL) is a significant hematologic malignancy.
- Establishing well-characterized in vitro models is crucial for studying lymphoma biology and developing therapies.
- Human NHL xenografts provide a source for generating relevant cell lines.
Purpose of the Study:
- To establish and characterize a novel in vitro cell line from a human B-cell NHL xenograft.
- To assess the retention of key lymphoma characteristics in the established cell line.
- To investigate the molecular and functional properties of the new cell line.
Main Methods:
- Establishment of an in vitro cell line (HT 58) from a human B-cell NHL xenograft.
- Analysis of cellular morphology, DNA content, and immunophenotypic markers.
- Karyotyping to identify clonal chromosomal abnormalities.
- Detection and characterization of expressed and produced molecules, including proteoglycans and secreted proteins.
Main Results:
- The HT 58 cell line retained lymphoblastic morphology, DNA content, and IgM/lambda monoclonality.
- Key immunophenotypic markers and clonal chromosomal abnormalities (chromosomes 1, 2, 3, 14) were maintained.
- Cells expressed and produced chondroitin sulfate proteoglycans (CSPG) and secreted IgM.
- The cells released substances that stimulated the proliferation of activated normal peripheral B-cells.
Conclusions:
- The HT 58 cell line is a valuable in vitro model for human B-cell NHL.
- This cell line retains critical biological and genetic features of the original lymphoma.
- The secreted factors suggest a potential role in modulating the tumor microenvironment and B-cell immunity.
Abstract:
An in vitro cell line (HT 58) has been established from a human (B) NHL xenograft. The lymphoma cells in culture retained their lymphoblastic appearance, DNA-content, IgM/lambda monoclonality and many immunophenotypic markers. The clonal chromosomal abnormalities involved the chromosomes 1, 2, 3 and 14. The cells expressed and produced chondroitin sulfate proteoglycans identified with mAbs that were raised against human articular cartilage CSPG. The cells also released IgM into the medium as well as substances that stimulated the proliferation of activated normal peripheral B-cells.